Skip to main content

Pharma News

 

Clinical courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease

    The U.S. Food and Drug Administration approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), to be used along with diet and exercise.

  • Study drugs set the stage for other drug use and mental health decline

    Taking study drugs like Adderall without a diagnosis is not only dangerous in itself, but can lead to other drug use and a decline in mental health, according to new research from Binghamton University.

  • Study shows adding folic acid to table salt could prevent life-threatening birth defects

    A team of international researchers including experts from the University of Central Florida and Emory University has proven, for the first time in a field study, that using folic acid-fortified iodized table salt can prevent multiple severe birth defects.

  • AstraZeneca Pharma India Ltd and Mankind Pharma partner to accelerate access to asthma medicine for patients in India

    AstraZeneca Pharma India Limited and Mankind Pharma Limited entered into an agreement for exclusive distribution of AstraZeneca's budesonide and formoterol fumarate dihydrate (inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination) brand Symbicort in India. AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be the Marketing Authorisation Holder (MAH) and import license.

  • DTAB promotes to affix barcode or QR code on vaccine labels

    DTAB was apprised that WHO Benchmarking is a process of assessment of National Regulatory Authority (NRA) based on Global Benchmarking Tools (GBT) done by team from WHO. Global Benchmarking of vaccine is the tool followed by WHO that involves the implementation of various regulatory functions at relevant institute of India including CDSCO as NRA.

  • WHO launches new manual to support delivery of psychological interventions

    By providing practical guidance on how to implement psychological interventions, this guide will help increase access to evidence-based interventions so that more people can benefit from them. The manual focuses on evidence-based psychological intervention manuals delivered by a non-specialist workforce.

  • More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study

    Eli Lilly and Company announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color and moderate-to-severe atopic dermatitis, commonly called eczema. In this study, treatment with lebrikizumab, an investigational medicine, showed improvement in skin clearance and itch relief. These late-breaking results from a Phase 3 study are being presented today at the American Academy of Dermatology (AAD) Annual Meeting.

  • FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight

    The U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight. Wegovy should be used in addition to a reduced calorie diet and increased physical activity. Cardiovascular disease is a group of diseases of the heart and blood vessels.

  • Reflecting on the Success of Drug Safety Symposium 2024

    Drug Safety Symposium 2024 unfolded as a beacon of innovation, collaboration, and excellence in the realm of Pharmacovigilance, Regulatory Affairs, and Quality Assurance. Held on February 14th -15th, 2024 at the Holiday Inn & Suites, the symposium marked a milestone in advancing drug safety standards and fostering transformative dialogue within the pharma industry.

  • Rising of Indian Medical Device Industries

    Medical devices industry is considered as one of Indias sunrise sectors. India is amongst the worlds fastest emerging Medical Device market with exports from the sector growing steadily at a CAGR of around 14 percent since FY 2019-20. The market for medical device industry in India is currently estimated to be of the size of USD 11 billion and it is expected to cross USD 30 billion mark by 2050.

Subscribe to Pharma News